Uric acid stone disease

被引:20
作者
Moran, ME [1 ]
机构
[1] Peters Kidney Stone Ctr, Albany, NY USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2003年 / 8卷
关键词
uric acid; calculi; xanthine; 2-8; dihydroxyadenine; allopurinol; purine; metabolism; review;
D O I
10.2741/1178
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The trend in uric acid stone formation appears to be on the rise again throughout much of the world. This is thought secondary to diet, body habitus, and social reasons. Uric acid stone disease has a rich and fascinating medical history and probably is the oldest known stone disease. Uric acid stone disease is strongly linked to the purine metabolic pathway, and its treatment is primarily medical. Uric acid stone disease can be prevented and these are one of the few urinary tract stones that can be dissolved successfully. Surgical intervention with uric acid stone disease represents a failure of medical therapy and a whole host of modern, minimally invasive methods are available for treating patients with this disease. Finally, uric acid nephrolithiasis is associated with a variety of inborn errors of metabolism based on mutations of key enzymes in the purine metabolic pathways. This review of uric acid stone formation will start with historical consideration, review basic biochemistry, and physiology and then focus upon specific clinical scenarios. The discussions will be heavily referenced for those interested in greater details.
引用
收藏
页码:S1339 / S1355
页数:17
相关论文
共 160 条
[111]   THE TREATMENT OF URIC-ACID CALCULI WITH EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY [J].
ROYCE, PL ;
FUCHS, GJ ;
LUPU, AN ;
CHAUSSY, CG .
BRITISH JOURNAL OF UROLOGY, 1987, 60 (01) :6-9
[112]   EXPERIMENTAL-OBSERVATIONS ON DISSOLUTION OF URIC-ACID CALCULI [J].
SADI, MV ;
SALTZMAN, N ;
FERIA, G ;
GITTES, RF .
JOURNAL OF UROLOGY, 1985, 134 (03) :575-579
[113]  
Safranow K, 2000, Ann Acad Med Stetin, V46, P35
[114]   CONTRASTING EFFECTS OF POTASSIUM CITRATE AND SODIUM-CITRATE THERAPIES ON URINARY CHEMISTRIES AND CRYSTALLIZATION OF STONE-FORMING SALTS [J].
SAKHAEE, K ;
NICAR, M ;
HILL, K ;
PAK, CYC .
KIDNEY INTERNATIONAL, 1983, 24 (03) :348-352
[115]   URICOSURIC EFFECT OF CGS-12970, A NEW THROMBOXANE SYNTHASE INHIBITOR [J].
SARIS, SD ;
PIRAINO, AJ ;
MORGAN, JM ;
HIRSCHHORN, WL ;
MEIDL, E ;
SCHAFFER, AV .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (01) :65-69
[116]   HYPERURICEMIA IN PATIENTS WITH HYPERTHYROIDISM DUE TO GRAVES-DISEASE [J].
SATO, A ;
SHIROTA, T ;
SHINODA, T ;
KOMIYA, I ;
AIZAWA, T ;
TAKEMURA, Y ;
YAMADA, T .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (02) :207-211
[117]   Helical CT of urinary calculi: Effect of stone composition, stone size, and scan collimation [J].
Saw, KC ;
McAteer, JA ;
Monga, AG ;
Chua, GT ;
Lingeman, JE ;
Williams, JC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 175 (02) :329-332
[118]   ENZYME DEFECT ASSOCIATED WITH A SEX-LINKED HUMAN NEUROLOGICAL DISORDER AND EXCESSIVE PURINE SYNTHESIS [J].
SEEGMILLER, JE ;
ROSENBLOOM, FM ;
KELLEY, WN .
SCIENCE, 1967, 155 (3770) :1682-+
[119]   CHEMODISSOLUTION OF URINARY URIC-ACID STONES BY ALKALI THERAPY [J].
SHARMA, SK ;
INDUDHARA, R .
UROLOGIA INTERNATIONALIS, 1992, 48 (01) :81-86
[120]  
SHATTOCK SG, 1908, PHILOS T R SOC LOND, P110